Cepheid Company Profile (NASDAQ:CPHD)

About Cepheid

Cepheid logoCepheid is a molecular diagnostics company. The Company develops, manufactures and markets fully-integrated systems for testing in the Clinical and Non-Clinical markets. The Company's systems enable molecular testing for organisms and genetic-based diseases by automating otherwise complex manual laboratory procedures. The Company's systems integrate these steps and analyze biological samples in test cartridges. Its primary offering is the GeneXpert system, which integrates sample preparation in addition to Deoxyribonucleic acid (DNA) amplification and detection. The GeneXpert system is designed for a range of user types ranging from reference laboratories and hospital central laboratories to satellite testing locations, such as emergency departments and intensive care units within hospitals, as well as physician offices and other alternate site laboratories. It also offers the SmartCycler system, which integrates DNA amplification and detection to allow rapid analysis of a sample.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Scientific & Technical Instruments
  • Sub-Industry: Biotechnology
  • Exchange: NASDAQ
  • Symbol: CPHD
  • CUSIP: 15670R10
Key Metrics:
  • Previous Close: $52.95
  • 50 Day Moving Average: $52.75
  • 200 Day Moving Average: $38.36
  • 52-Week Range: $25.09 - $53.91
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: 53.48
  • P/E Growth: 0.00
  • Market Cap: $N/A
  • Beta: 0.67
  • Net Margins: -6.30%
  • Return on Equity: -7.92%
  • Return on Assets: -3.58%
  • Debt-to-Equity Ratio: 0.76%
  • Current Ratio: 4.30%
  • Quick Ratio: 3.24%
Additional Links:
Companies Related to Cepheid:

Analyst Ratings

Consensus Ratings for Cepheid (NASDAQ:CPHD) (?)
Ratings Breakdown: 12 Hold Ratings, 2 Buy Ratings
Consensus Rating:Hold (Score: 2.14)
Consensus Price Target: $42.89 (19.00% downside)

Analysts' Ratings History for Cepheid (NASDAQ:CPHD)
DateFirmActionRatingPrice TargetDetails
11/22/2016Canaccord GenuityReiterated RatingHoldView Rating Details
9/12/2016Robert W. BairdDowngradeOutperform -> Neutral$53.00View Rating Details
9/8/2016Citigroup Inc.DowngradeBuy -> Neutral$44.00 -> $53.00View Rating Details
9/7/2016Barclays PLCBoost Price TargetEqual Weight$36.00 -> $52.00View Rating Details
9/7/2016BTIG ResearchDowngradeBuy -> NeutralView Rating Details
9/7/2016Cowen and CompanyDowngradeOutperform -> Market PerformView Rating Details
9/6/2016Craig HallumDowngradeBuy -> HoldView Rating Details
9/6/2016Piper Jaffray CompaniesDowngradeOverweight -> NeutralView Rating Details
9/6/2016Needham & Company LLCDowngradeBuy -> HoldView Rating Details
8/17/2016Jefferies Group LLCBoost Price TargetHold$28.00 -> $34.00View Rating Details
7/29/2016J P Morgan Chase & CoBoost Price TargetNeutral$32.00 -> $35.00View Rating Details
6/15/2016Morgan StanleyInitiated CoverageEqual Weight$30.00View Rating Details
4/1/2016Atlantic SecuritiesUpgradeNeutral -> OverweightView Rating Details
3/28/2016WedbushLower Price TargetOutperform$58.00 -> $55.00View Rating Details
2/3/2016Stifel NicolausLower Price TargetBuy$42.00 -> $38.00View Rating Details
2/3/2016Leerink SwannReiterated RatingMarket Perform$39.00 -> $33.00View Rating Details
1/6/2016Avondale PartnersInitiated CoverageOutperform$46.00View Rating Details
12/2/2015Wells Fargo & CompanyDowngradeOutperform -> Market PerformView Rating Details
10/21/2015Evercore ISIUpgradeSell -> Hold$44.50 -> $32.50View Rating Details
10/21/2015MizuhoLower Price TargetBuy$60.00 -> $42.00View Rating Details
10/14/2015Goldman Sachs Group, Inc. (The)Lower Price Target$53.00 -> $30.00View Rating Details
10/14/2015Raymond James Financial, Inc.DowngradeOutperform -> Market PerformView Rating Details
7/26/2015MKM PartnersReiterated RatingBuy$65.00 -> $72.00View Rating Details
7/24/2015Evercore Partners Inc.Reiterated RatingHold -> SellView Rating Details
4/26/2015Cantor FitzgeraldReiterated RatingBuy$62.00View Rating Details
4/24/2015JMP SecuritiesBoost Price TargetMarket Outperform$58.00 -> $67.00View Rating Details
(Data available from 2/23/2015 forward)


Earnings History for Cepheid (NASDAQ:CPHD)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
7/28/2016Q216($0.14)$0.05$145.82 million$146.00 millionViewListenView Earnings Details
4/28/2016Q116$0.01$0.08$140.35 million$144.80 millionViewN/AView Earnings Details
2/2/2016Q415($0.20)$0.07$146.95 million$147.00 millionViewN/AView Earnings Details
10/20/2015Q3($0.31)($0.13)$126.81 million$126.50 millionViewListenView Earnings Details
7/23/2015Q215($0.21)($0.06)$130.70 million$132.50 millionViewListenView Earnings Details
4/23/2015Q115($0.16)$0.01$125.50 million$132.60 millionViewN/AView Earnings Details
1/29/2015Q414($0.13)$0.11$125.34 million$131.50 millionViewN/AView Earnings Details
10/16/2014Q314($0.16)$0.06$110.10 million$115.20 millionViewListenView Earnings Details
7/17/2014Q214($0.13)$0.03$115.47 million$116.50 millionViewN/AView Earnings Details
4/17/2014Q114($0.17)($0.01)$104.90 million$106.90 millionViewN/AView Earnings Details
1/31/2014Q413($0.11)($0.15)$102.17 million$113.30 millionViewN/AView Earnings Details
10/17/2013Q313($0.11)($0.20)$93.70 million$100.10 millionViewN/AView Earnings Details
7/18/2013Q2 2013$0.04$0.02$92.57 million$96.00 millionViewN/AView Earnings Details
4/18/2013Q1 2013$0.10$0.11$89.12 million$91.90 millionViewN/AView Earnings Details
1/24/2013Q4 2012$0.11$0.20$92.87 million$92.40 millionViewN/AView Earnings Details
10/18/2012($0.07)($0.32)ViewN/AView Earnings Details
7/19/2012$0.11$0.11ViewN/AView Earnings Details
4/19/2012($0.01)($0.08)ViewN/AView Earnings Details
1/26/2012($0.02)($0.03)ViewN/AView Earnings Details
10/20/2011$0.02$0.03ViewN/AView Earnings Details
7/21/2011($0.01)$0.03ViewN/AView Earnings Details
4/20/2011($0.01)$0.01ViewN/AView Earnings Details
1/27/2011($0.02)$0.02ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)


Earnings Estimates for Cepheid (NASDAQ:CPHD)
Current Year EPS Consensus Estimate: $0.33 EPS
Next Year EPS Consensus Estimate: $0.99 EPS
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20162($0.26)($0.16)($0.21)
Q2 20163($0.20)($0.17)($0.18)
Q3 20163($0.18)($0.11)($0.15)
Q4 20162($0.03)($0.01)($0.02)
(Data provided by Zacks Investment Research)


Dividend History for Cepheid (NASDAQ:CPHD)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for Cepheid (NASDAQ:CPHD)
Insider Ownership Percentage: 4.16%
Institutional Ownership Percentage: 95.75%
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
8/17/2016Scott A CampbellVPSell287$36.16$10,377.92View SEC Filing  
8/4/2016Scott A CampbellVPSell746$36.71$27,385.66View SEC Filing  
5/3/2016Scott A CampbellVPSell2,058$27.90$57,418.20View SEC Filing  
5/2/2016Peter V FarrellEVPSell390$28.90$11,271.00View SEC Filing  
4/28/2016Peter V FarrellEVPSell390$36.30$14,157.00View SEC Filing  
4/25/2016John L BishopCEOSell110,000$35.50$3,905,000.00View SEC Filing  
3/10/2016Peter V FarrellEVPSell393$33.01$12,972.93View SEC Filing  
2/8/2016Warren C. Kocmond, Jr.COOSell292$28.53$8,330.76View SEC Filing  
2/1/2016Warren C. Kocmond, Jr.COOSell351$28.44$9,982.44View SEC Filing  
1/22/2016Warren C. Kocmond, Jr.COOSell157$33.16$5,206.12View SEC Filing  
12/10/2015Peter V. FarrellEVPSell394$31.67$12,477.98View SEC Filing  
11/20/2015Robert J EastonDirectorSell3,206$36.02$115,480.12View SEC Filing  
11/17/2015Robert J EastonDirectorSell2,724$34.84$94,904.16View SEC Filing  
11/12/2015Robert J EastonDirectorSell2,556$35.01$89,485.56View SEC Filing  
10/30/2015Peter V. FarrellEVPSell1,560$33.89$52,868.40View SEC Filing  
8/27/2015Peter V. FarrellEVPSell1,577$48.67$76,752.59View SEC Filing  
8/25/2015Cristina KepnerDirectorBuy10,000$47.78$477,800.00View SEC Filing  
6/26/2015Warren C Kocmond JrCOOSell9,375$61.52$576,750.00View SEC Filing  
4/29/2015Thomas L GutshallDirectorSell1,800$56.62$101,916.00View SEC Filing  
4/21/2015Joseph H SmithEVPSell91,866$54.51$5,007,615.66View SEC Filing  
4/20/2015John L BishopCEOSell100,000$55.20$5,520,000.00View SEC Filing  
2/25/2015Hollings RentonDirectorSell9,375$57.76$541,500.00View SEC Filing  
2/13/2015Dean O MortonDirectorSell12,500$58.51$731,375.00View SEC Filing  
2/3/2015Thomas D BrownDirectorSell12,500$56.29$703,625.00View SEC Filing  
1/30/2015Andrew MillerCFOSell6,677$57.64$384,862.28View SEC Filing  
1/12/2015Andrew MillerCFOSell11,719$56.65$663,881.35View SEC Filing  
1/12/2015David H PersingEVPSell5,000$56.90$284,500.00View SEC Filing  
1/12/2015Warren C Kocmond JrCOOSell4,688$57.00$267,216.00View SEC Filing  
1/5/2015Andrew MillerCFOSell2,250$54.95$123,637.50View SEC Filing  
1/5/2015Kerry FlomEVPSell8,694$54.21$471,301.74View SEC Filing  
11/19/2014Dean O MortonDirectorSell11,849$52.96$627,523.04View SEC Filing  
11/7/2014Hollings RentonDirectorSell9,375$51.07$478,781.25View SEC Filing  
10/31/2014Andrew MillerCFOSell12,167$53.84$655,071.28View SEC Filing  
10/31/2014David H PersingEVPSell20,000$53.34$1,066,800.00View SEC Filing  
10/31/2014Dean O MortonDirectorSell7,500$52.64$394,800.00View SEC Filing  
10/29/2014Kerry FlomEVPSell7,077$51.36$363,474.72View SEC Filing  
10/29/2014Thomas L GutshallDirectorSell12,500$51.63$645,375.00View SEC Filing  
10/28/2014David H PersingEVPSell15,000$51.51$772,650.00View SEC Filing  
10/3/2014Kerry FlomEVPSell1,271$44.52$56,584.92View SEC Filing  
8/7/2014Warren C Kocmond JrEVPSell324$38.69$12,535.56View SEC Filing  
7/14/2014Kerry FlomEVPSell2,812$49.72$139,812.64View SEC Filing  
7/3/2014Kerry FlomEVPSell1,282$48.97$62,779.54View SEC Filing  
5/29/2014Kerry FlomEVPSell4,265$45.49$194,014.85View SEC Filing  
5/22/2014Warren C Kocmond JrEVPSell1,300$42.38$55,094.00View SEC Filing  
4/29/2014Kerry FlomEVPSell2,660$42.38$112,730.80View SEC Filing  
4/25/2014John BishopCEOSell107,651$43.93$4,729,108.43View SEC Filing  
4/22/2014John BishopCEOSell42,349$46.11$1,952,712.39View SEC Filing  
4/22/2014Robert EastonDirectorSell12,500$45.59$569,875.00View SEC Filing  
4/3/2014Kerry FlomEVPSell1,621$51.55$83,562.55View SEC Filing  
4/1/2014Andrew MillerCFOSell4,688$52.78$247,432.64View SEC Filing  
3/13/2014Andrew MillerCFOSell17,265$55.55$959,070.75View SEC Filing  
1/31/2014Andrew MillerCFOSell63,375$53.10$3,365,212.50View SEC Filing  
1/31/2014John BishopCEOSell150,000$50.67$7,600,500.00View SEC Filing  
1/31/2014Joseph SmithEVPSell50,000$51.15$2,557,500.00View SEC Filing  
1/3/2014Kerry FlomEVPSell6,357$45.66$290,260.62View SEC Filing  
1/2/2014Andrew MillerCFOSell2,437$45.92$111,907.04View SEC Filing  
12/23/2013Kerry FlomEVPSell10,000$46.51$465,100.00View SEC Filing  
10/30/2013David H PersingVPSell5,000$41.35$206,750.00View SEC Filing  
10/29/2013Kerry FlomEVPSell2,660$40.50$107,730.00View SEC Filing  
10/24/2013Thomas L GutshallDirectorSell3,000$40.07$120,210.00View SEC Filing  
10/18/2013David H PersingVPSell20,000$40.59$811,800.00View SEC Filing  
9/24/2013Thomas GutshallDirectorSell3,000$38.97$116,910.00View SEC Filing  
9/18/2013David PersingVPSell5,000$39.34$196,700.00View SEC Filing  
9/16/2013David PersingVPSell5,000$38.95$194,750.00View SEC Filing  
9/6/2013David H PersingVPSell20,000$37.99$759,800.00View SEC Filing  
8/30/2013David PersingVPSell5,129$36.62$187,823.98View SEC Filing  
8/26/2013Thomas GutshallDirectorSell3,000$36.38$109,140.00View SEC Filing  
8/21/2013Robert EastonDirectorSell7,500$35.01$262,575.00View SEC Filing  
7/24/2013Thomas L GutshallDirectorSell3,000$34.18$102,540.00View SEC Filing  
6/24/2013Thomas L GutshallDirectorSell3,000$32.91$98,730.00View SEC Filing  
5/28/2013Andrew MillerCFOSell22,468$38.51$865,242.68View SEC Filing  
5/24/2013Thomas L GutshallDirectorSell3,000$37.90$113,700.00View SEC Filing  
5/13/2013Kerry FlomEVPSell6,832$39.76$271,640.32View SEC Filing  
3/25/2013Thomas L GutshallDirectorSell3,000$38.28$114,840.00View SEC Filing  
2/4/2013Joseph H SmithEVPSell38,400$36.20$1,390,080.00View SEC Filing  
12/24/2012Thomas L GutshallDirectorSell3,000$33.06$99,180.00View SEC Filing  
11/26/2012Thomas L GutshallDirectorSell7,778$31.94$248,429.32View SEC Filing  
(Data available from 1/1/2013 forward)


Latest Headlines for Cepheid (NASDAQ:CPHD)
finance.yahoo.com logoMario Gabelli Comments on Cepheid (NASDAQ:CPHD)
finance.yahoo.com - January 31 at 4:58 PM
News IconAs Cepheid (CPHD) Stock Rose, Shareholder Riverbridge Partners LLC Has Cut by $4.38 Million Its Position (NASDAQ:CPHD)
randolphguide.com - January 27 at 5:53 PM
News IconEarnings in Full Force, Analysts Take Aim at CEPHEID (NASDAQ:CPHD) - Wall Street Beacon (NASDAQ:CPHD)
wsbeacon.com - January 24 at 10:05 PM
News IconAnalysts Pounding The Pavement on CEPHEID (NASDAQ:CPHD): Consensus Update - Wall Street Beacon (NASDAQ:CPHD)
wsbeacon.com - January 23 at 9:49 PM
News IconDevling Into Shares of CEPHEID (NASDAQ:CPHD), What Are Analysts Predicting for 2017? - Wall Street Beacon (NASDAQ:CPHD)
wsbeacon.com - January 20 at 3:50 AM
nasdaq.com logoIntegrated Investment Consultants, LLC Buys Vanguard FTSE Emerging Markets, Mylan NV, Omega ... (NASDAQ:CPHD)
www.nasdaq.com - January 19 at 10:48 PM
marketrealist.com logoBehind Danaher’s 4Q16 Revenue Estimates (NASDAQ:CPHD)
marketrealist.com - January 17 at 5:18 PM
News IconWall Street and Armchair Analysts Weigh in on CEPHEID (NASDAQ:CPHD) Heading Into The New Year - Wall Street Beacon (NASDAQ:CPHD)
wsbeacon.com - January 17 at 8:55 AM
News IconInstitutional Move From SEC: As Cepheid (CPHD) Market Value Rose, Holder Springbok Capital Management LLC ... - The Herald Beacon (NASDAQ:CPHD)
heraldbeacon.com - January 17 at 8:55 AM
insidermonkey.com logo5 Healthcare Stocks Billionaires Are Buying (NASDAQ:CPHD)
www.insidermonkey.com - December 28 at 12:10 PM
insidermonkey.com logoHere is What Hedge Funds Think About Clear Channel Outdoor Holdings, Inc. (CCO) (NASDAQ:CPHD)
www.insidermonkey.com - December 28 at 12:10 PM
seekingalpha.com logoDanaher initiates 2017 outlook (NASDAQ:CPHD)
seekingalpha.com - December 15 at 4:53 PM
insidermonkey.com logoIs Chemed Corporation (CHE) Going to Burn These Hedge Funds? (NASDAQ:CPHD)
www.insidermonkey.com - December 4 at 11:23 AM
News IconCepheid (CPHD): What Smart Money Thinks about This Stock? (NASDAQ:CPHD)
feedproxy.google.com - November 30 at 2:15 PM
News IconCEPHEID (NASDAQ:CPHD) Under Analyst Spotlight - UK Market News (NASDAQ:CPHD)
www.ukmarketnews.co.uk - November 22 at 10:02 PM
News IconSell-side Consensus Sees CEPHEID (NASDAQ:CPHD) Going Where Near-Term? - CSZ News (NASDAQ:CPHD)
cincysportszone.com - November 22 at 3:56 PM
finance.yahoo.com logoCEPHEID Financials (NASDAQ:CPHD)
finance.yahoo.com - November 15 at 4:40 PM
biz.yahoo.com logoCEPHEID Files SEC form 8-K, Completion of Acquisition or Disposition of Assets, Triggering Events That Accelerate or (NASDAQ:CPHD)
biz.yahoo.com - November 7 at 11:02 PM
News IconNarrowing in on Chart Levels for Cepheid (CPHD) - Wall Street Confidential (NASDAQ:CPHD)
wsconfidential.com - November 7 at 7:55 AM
streetinsider.com logoDanaher (DHR) Announces Completion of Cepheid (CPHD) Acquisition - StreetInsider.com (NASDAQ:CPHD)
www.streetinsider.com - November 7 at 7:55 AM
publicnow.com logoDanaher Completes Acquisition Of Cepheid (NASDAQ:CPHD)
www.publicnow.com - November 4 at 8:51 PM
biz.yahoo.com logoCEPHEID Files SEC form 10-Q, Quarterly Report (NASDAQ:CPHD)
biz.yahoo.com - November 3 at 9:56 PM
News IconTrending Stock – Cepheid's (CPHD) | Hot Stocks Point - Hot Stocks Point (NASDAQ:CPHD)
www.hotstockspoint.com - October 31 at 4:27 PM
News IconIntraday Mover - Cepheid's (CPHD) - Hot Stocks Point (NASDAQ:CPHD)
www.hotstockspoint.com - October 29 at 11:27 AM
biz.yahoo.com logoCEPHEID Files SEC form 8-K, Change in Directors or Principal Officers (NASDAQ:CPHD)
biz.yahoo.com - October 28 at 9:11 PM
feeds.reuters.com logoBRIEF-Cepheid says CEO John Bishop to resign (NASDAQ:CPHD)
feeds.reuters.com - October 28 at 5:48 PM
publicnow.com logo30 Minute Or Less Molecular Flu/RSV Test Now Available Outside The US (NASDAQ:CPHD)
www.publicnow.com - October 27 at 8:55 AM
nasdaq.com logoIWO, MSCC, AZPN, CPHD: Large Outflows Detected at ETF (NASDAQ:CPHD)
www.nasdaq.com - October 25 at 9:37 PM
mysmartrend.com logoCepheid Shares Up 77.9% Since SmarTrend's Buy Recommendation (CPHD) (NASDAQ:CPHD)
www.mysmartrend.com - October 25 at 9:37 PM
News IconStocks on Hotspot- Visa Inc. (NYSE:V), Cepheid (NASDAQ:CPHD), Neuberger Berman Real Estate Securities Income ... - Seneca Globe (NASDAQ:CPHD)
www.senecaglobe.com - October 25 at 4:26 PM
nasdaq.com logoCepheid Says Receives Regulatory Clearances In Proposed Acquisition By Danaher (NASDAQ:CPHD)
www.nasdaq.com - October 24 at 4:16 PM
streetinsider.com logoCepheid (CPHD) Announces Final Regulatory Hurdles Cleared to Close Danaher (DHR) Merger (NASDAQ:CPHD)
www.streetinsider.com - October 24 at 4:16 PM
feeds.reuters.com logoBRIEF-Cepheid receives required regulatory clearances in proposed acquisition by Danaher (NASDAQ:CPHD)
feeds.reuters.com - October 24 at 9:45 AM
streetinsider.com logoCepheid (CPHD) Announces Final Regulatory Hurdles Cleared to Close Danaher (DHR) Merger - StreetInsider.com (NASDAQ:CPHD)
www.streetinsider.com - October 24 at 9:34 AM
biz.yahoo.com logoCEPHEID Files SEC form 8-K, Other Events, Financial Statements and Exhibits (NASDAQ:CPHD)
biz.yahoo.com - October 24 at 9:33 AM
publicnow.com logoCepheid Announces Receipt of Required Regulatory Clearances in Proposed Acquisition by Danaher Corporation (NASDAQ:CPHD)
www.publicnow.com - October 24 at 9:33 AM
istreetwire.com logoStocks Trend Analysis: Ruby Tuesday, Inc. (RT) Xilinx Inc. (XLNX) Cepheid (CPHD) - iStreetWire (NASDAQ:CPHD)
istreetwire.com - October 19 at 9:18 AM
mysmartrend.com logoShares of CPHD Up 77.1% Since Uptrend Call on Shares (NASDAQ:CPHD)
www.mysmartrend.com - October 17 at 4:22 PM
finance.yahoo.com logoWhat's in Store for Cepheid (CPHD) this Earnings Season? (NASDAQ:CPHD)
finance.yahoo.com - October 17 at 4:22 PM
News IconOverbuying Alert on: Cepheid (NASDAQ:CPHD) | | Post Registrar - Post Registrar (NASDAQ:CPHD)
postregistrar.com - October 15 at 4:14 PM
nasdaq.com logoiShares Russell 2000 Growth ETF Experiences Big Outflow (NASDAQ:CPHD)
www.nasdaq.com - October 14 at 4:15 PM
News IconUpdate on Cepheid (NASDAQ:CPHD) for the day (NASDAQ:CPHD)
twincountynews.com - October 14 at 4:15 PM
finance.yahoo.com logoExactech Enters Foot & Ankle Space with Vantage System (NASDAQ:CPHD)
finance.yahoo.com - October 14 at 4:15 PM
News IconMover to Watch - Cepheid's (CPHD) - Hot Stocks Point (NASDAQ:CPHD)
www.hotstockspoint.com - October 13 at 4:16 PM
finance.yahoo.com logoPatterson Companies & Heartland Dental Form Partnership (NASDAQ:CPHD)
finance.yahoo.com - October 12 at 9:05 AM
marketrealist.com logoWhy Danaher Is Relatively Immune from Growth Concerns in China (NASDAQ:CPHD)
marketrealist.com - October 11 at 4:30 PM
zacks.com logoCepheid: Commercial Launch of Xpert Bladder Cancer Monitor (NASDAQ:CPHD)
www.zacks.com - October 10 at 9:06 AM
seekingalpha.com logoWarren Buffett's Trade (NASDAQ:CPHD)
seekingalpha.com - October 8 at 9:06 AM
finance.yahoo.com logoColumbia Wanger Sold 2 Stakes in September (NASDAQ:CPHD)
finance.yahoo.com - October 8 at 9:06 AM
streetinsider.com logoCepheid (CPHD) Announces Commercial Launch of Xpert Bladder Cancer Monitor in CE Mark Countries - StreetInsider.com (NASDAQ:CPHD)
www.streetinsider.com - October 7 at 9:20 AM


What is Cepheid's stock symbol?

Cepheid trades on the NASDAQ under the ticker symbol "CPHD."

Where is Cepheid's stock going? Where will Cepheid's stock price be in 2017?

14 brokers have issued 1 year price targets for Cepheid's stock. Their predictions range from $30.00 to $55.00. On average, they expect Cepheid's stock price to reach $42.89 in the next twelve months.

When will Cepheid announce their earnings?

Cepheid is scheduled to release their next quarterly earnings announcement on Tuesday, November, 8th 2016.

Who owns Cepheid stock?

Cepheid's stock is owned by many different of retail and institutional investors. Top institutional shareholders include Fifth Third Bancorp (0.00%). Company insiders that own Cepheid stock include Cristina Kepner, Hollings Renton, John L Bishop, Joseph H Smith, Peter V Farrell, Robert J Easton, Scott A Campbell, Thomas L Gutshall, Warren C Kocmond Jr and Warren C Kocmond, Jr.

How do I buy Cepheid stock?

Shares of Cepheid can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

How much does a share of Cepheid stock cost?

One share of Cepheid stock can currently be purchased for approximately $52.95.

Cepheid (NASDAQ:CPHD) Chart for Thursday, February, 23, 2017

Institutional Ownership Chart

Institutional Ownership by Quarter for Cepheid (NASDAQ:CPHD)

Earnings History Chart

Earnings by Quarter for Cepheid (NASDAQ:CPHD)

Dividend History Chart

Dividend Payments by Quarter for Cepheid (NASDAQ:CPHD)

Last Updated on 2/23/2017 by MarketBeat.com Staff